Tyra Biosciences Ownership | Who Owns Tyra Biosciences?
Tyra Biosciences Ownership Summary
Tyra Biosciences is owned by 44.17% institutional investors, 3.15% insiders, and 52.68% retail investors. Ra capital management is the largest institutional shareholder, holding 20.48% of TYRA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.72% of its assets in Tyra Biosciences shares.
TYRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tyra Biosciences | 44.17% | 3.15% | 52.68% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 12.20M | 20.48% | $170.66M |
| Boxer capital | 6.45M | 12.35% | $103.11M |
| Nextech invest | 4.06M | 6.89% | $56.38M |
| Nextech invest | 4.06M | 6.81% | $56.74M |
| Alta partners management | 3.82M | 6.41% | $100.52M |
| Bvf inc/il | 3.65M | 6.13% | $51.06M |
| Canaan partners xi | 3.61M | 6.06% | $50.48M |
| Commodore capital lp | 3.38M | 5.67% | $47.22M |
| Tcg crossover management | 2.90M | 4.87% | $40.54M |
| Vestal point capital, lp | 2.42M | 4.07% | $33.93M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alta partners management | 3.82M | 97.03% | $100.52M |
| Canaan partners xi | 3.61M | 49.07% | $50.48M |
| Nextech invest | 4.06M | 9.15% | $56.38M |
| Nextech invest | 4.06M | 8.64% | $56.74M |
| Boxer capital | 6.45M | 5.43% | $103.11M |
| 5am venture management | 939.30K | 4.81% | $13.14M |
| Investment counsel co of nevada | 85.02K | 4.80% | $2.24M |
| Kynam capital management, lp | 2.33M | 2.43% | $32.60M |
| Commodore capital lp | 3.38M | 2.31% | $47.22M |
| Ra capital management | 12.20M | 2.10% | $170.66M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 1.75M | 0.01% | 679.12K |
| Caligan partners lp | 696.83K | 1.28% | 506.88K |
| Blackrock | 1.42M | 0.00% | 374.63K |
| Balyasny asset management | 583.39K | 0.01% | 340.14K |
| Millennium management | 315.14K | 0.00% | 304.64K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fairmount funds management | - | - | -1.39M |
| Orbimed advisors | - | - | -804.60K |
| Perceptive advisors | - | - | -511.23K |
| Pictet asset management sa | - | - | -459.11K |
| First turn management | - | - | -381.21K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Eversept partners, lp | 272.71K | 0.26% | 272.71K | $3.82M |
| Boothbay fund management | 186.67K | 0.04% | 186.67K | $2.61M |
| Axa investment managers | 128.79K | 0.00% | 128.79K | $1.80M |
| Soleus capital management | 125.00K | 0.12% | 125.00K | $3.29M |
| Y-intercept (hong kong) | 45.94K | 0.03% | 45.94K | $1.21M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -2.00 |
| Ifp advisors | -2.00 |
| Capital performance advisors llp | -5.00 |
| Corecap advisors | -16.00 |
| Coldstream capital management | -28.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 93 | -19.83% | 26,357,561 | -52.63% | 44 | 0.51% | 49 | - | 28 | -26.32% |
| Sep 30, 2025 | 115 | -4.17% | 55,638,535 | -1.68% | 93 | 1.03% | 49 | -40.24% | 38 | 90.00% |
| Jun 30, 2025 | 119 | 1.71% | 56,577,138 | 16.52% | 95 | 1.42% | 80 | 25.00% | 21 | -32.26% |
| Mar 31, 2025 | 118 | 4.42% | 53,572,784 | 10.20% | 90 | 1.32% | 64 | -8.57% | 31 | 24.00% |
| Dec 31, 2024 | 110 | 11.11% | 48,202,601 | 2.44% | 81 | 1.28% | 67 | 19.64% | 25 | 25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 917.27K | 1.72% | - |
| Fidelity Small Cap Growth | 800.38K | 1.51% | -113.05K |
| iShares Russell 2000 ETF | 620.34K | 1.16% | 372.77K |
| Fidelity Stock Selector Small Cap | 598.94K | 1.13% | - |
| Biotech Growth Ord | 580.15K | 1.09% | - |
| Fidelity Series Small Cap Opps | 508.83K | 0.96% | - |
| Fidelity Small Cap Growth K6 | 360.50K | 0.68% | -51.65K |
| iShares Biotechnology ETF | 269.43K | 0.50% | 269.43K |
| State Street® SPDR® S&P® Biotech ETF | 264.98K | 0.50% | -1.43K |
| Vanguard Institutional Extnd Mkt Idx Tr | 256.51K | 0.48% | -537.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 12, 2026 | Bensen Daniel | Chief Discovery Officer | Sell | $195.93K |
| Feb 12, 2026 | Bensen Daniel | Chief Discovery Officer | Sell | $67.04K |
| Jan 12, 2026 | Bensen Daniel | Chief Discovery Officer | Sell | $198.61K |
| Jan 12, 2026 | Bensen Daniel | Chief Discovery Officer | Sell | $29.58K |
| Dec 19, 2025 | MORE ROBERT J | - | Sell | $250.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | - |
| 2025 Q2 | 6 | 5 |
| 2025 Q1 | - | 8 |
TYRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools